Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-23-049039

Chief Business Officer sold 5,000 shares at $32.74 ($163,677)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Robb Gary Charles Chief Business Officer 2023-09-19 Sale −5,000 $32.74 $163,677 21,996 D
Open-market sales · 5,000 sh · avg $32.74 · $163,677
Loading xslF345X05/ownership.xml…